ReviewHuman vaccines & immunotherapeutics2014
The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patients.
Michelle Paff et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this papercites it